Bio

Buzz is a founding member of SightLine Partners. Prior to SightLine, Buzz founded Piper Jaffray's dedicated venture activities in 1992. Prior to 1992, he co-headed Piper Jaffray's Investment Banking activities focused on the healthcare industry for six years. In addition to his over 20 years of venture capital experience, Buzz has been actively involved in a broad range of transactions for healthcare companies including mergers and acquisitions, corporate partner agreements, public offerings and private placements of equity and debt. Prior to joining Piper Jaffray in 1986, Buzz was a partner at Stonebridge Capital, a partnership investing in emerging publicly traded companies. Previously, he was an investment officer with Cherry Tree Ventures, and a manager in the public accounting firm of Arthur Andersen & Co. Current Board Seats: Anulex, Broncus, iScience, LipoScience, Verax Biomedical. Selected Prior Board Seats or Involvement: Acorn Cardiovascular, CardioGenesis, Conceptus, CVRx, Endocardial Solutions, Endovascular Technologies, Exogen, InnerDyne, Innovasive Devices, Medintell Systems, Micro Interventional Systems, PacificDental Benefits, ProtoStar, Suros Surgical Systems, Urologix He is a graduate of St. John's University and a Certified Public Accountant.